About Us
Leadership Team
Won Sik Lee, MD, Ph.D
Chief Executive Officer
-
Former Director General of Pharmaceutical Safety Bureau at Korea Ministry of Food and Drug Safety
-
Involved in R&D and regulatory reform, ICH and IFAPP management committee, Leadership roles in various Pharmaceutical Medicine Society (e.g. KSCPT, KSPM, KSME)
-
Worked over 20 years for various Pharmaceuticals as Medical/Scientific Affairs Director at MSD, Sanofi, Handok, and Pfizer
-
Ph.D. in Pharmacology at Hanyang University
-
MS of Preventive Medicine at Seoul National University
-
Bachelor of Medicine at Seoul National University
Alan Choi, MD
Chief Science Officer
-
Head of Research and Development at Ildong Pharmaceutical Co., Ltd.
-
CEO at AIMS BioScience, a subsidiary company of Ildong Group
-
Chairman of Korea Society of Pharmaceutical Medicine
-
Multiple roles of prior company as an executive director at J&J Korea, engaged in various R&D projects, clinical operations, medical advisor and commercial unit
-
Adjunctive Professor at Youth and Child psychiatry at SMC (Samsung Medical Center), served as medical director at National Center for Mental Health
-
Bachelor of Medicine at Seoul National University
Jinsik Suh, MBA
Chief Strategy Officer
-
Chief Operating Officer at Ildong Pharmaceutical Co., Ltd.
-
Former Chief Finance Officer at Dongwon F&B and Janssen Korea (Johnson & Johnson) with multi-disciplinary project , supply chain improvement and optimizing back office operation
-
MBA, Darden School of Business at University of Virginia, CPA in Maryland, US
-
Bachelor of Business Administration at Seoul National University
Eun-Jihn Roh, R.Ph, M.S
Chief Development Officer
-
Total 15 years of industry experience, of which more than 10 years have been solely dedicated to Oncology clinical development
-
Former Oncology Project Lead at Pfizer Korea
-
Former Oncology Project Manager, Project Director and Customer Relationship Executive at Syneos Health
-
Provided consultancy to numerous oncology biotechs
-
Bachelor’s degree in pharmaceutical studies and master’s degree in pharmacology at Ewha Woman’s University
-
Registered pharmacist
Kyoung Soo Ha, MD, Ph.D.
Chief Medical Officer
-
15 years of industry experience, including 7 years of medical lead of multinational clinical trials in hemato-oncology area
-
Early / late phase global clinical development for oncology area as Sr. Medical Director / Chief Medical Officer at Sillajen and Archigen
-
Medical Affairs Director for diverse therapeutic area including cardiovascular metabolism and immunology at Sanofi, Novartis, and Abbott
-
Multiple hands-on experience of clinical trial start-ups from synopsis development into regulatory IND approval in Korea, US and EU
-
Ph.D. of Public Health (Epideimiology) & Bachelor of Medicine at Yonsei University
Eun Kyung Kang, R.Ph, MPH
Chief Regulatory and Quality Officer
-
Led RA/QA/PV with cross-functional projects at Guerbet Korea
-
Former RA/PV lead at SK Biopharmaceuticals
-
Handled a various type of registrations and product maintenance with the drug development experience from early stage
-
Worked at HIRA, involved in managing benefit standard and benefit adequacy
-
Master of Public Health at Yonsei University & Bachelor of pharmacy at Ewha Woman’s University
-
Registered pharmacist, Korea Regulatory Affair Certificate
Chae Joon Lee, MBA
Chief Business Officer
-
Chief Globalization Officer at Ildong Pharmaceutical Co., Ltd
-
Former Chief Executive Officer at Yungjin Pharmaceutical Co., Ltd
-
Former Senior VP in Global Business Headquarter at Dong-A ST/Dong-A Socio Holdings
-
Former Senior Director at GlaxoSmithKline, PLC
-
MBA, University of Michigan, Executive Business School
-
Bachelor of Applied Science at University of British Columbia
ASCO ANNUAL MEETING, 2021